Showing results (191-200 of 296) with videos related to

Sort By:
Pageof 30
Internal Medicine (Tokyo, Japan)|January 17, 2014
Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 yearsYao-Chung Liu, Jyh-Pyng Gau, Yuan-Bin Yu, et al.
Annals of Hematology|January 21, 2014
Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopeniaMing-Hung Hu, Yuan-Bin Yu, Yu-Chung Huang, et al.
Breast Cancer Research and Treatment|June 7, 2014
Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cellsChun-Yu Liu, Jung-Chen Su, Mei-Huei Ni, et al.
Ebiomedicine|January 18, 2019
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progressionChun-Yu Liu, Tzu-Ting Huang, Yi-Ting Chen, et al.
Cancer Research and Treatment|December 11, 2025
ITGB2 Gene Gain as a Prognostic Marker for Early Recurrence in Luminal HER2-Negative High Proliferative Breast CancerChun-Yu Liu, Ji-Lin Chen, Yi-Fang Tsai, et al.
Annals of Hematology|February 23, 2024
Comparing transfusion reactions between pre-storage and post-storage leukoreduced apheresis platelets: an analysis using propensity score matchingSheng-Hsuan Chien, Hsin-Yi Huang, Ying-Ju Chen, et al.
The Oncologist|November 23, 2023
Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian PatientsJiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, et al.
Circulation|June 20, 2007
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart StudyCaroline S Fox, Joseph M Massaro, Udo Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2017
Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or FulvestrantPei-Yin Hsu, Victoria Shang Wu, Noriko Kanaya, et al.
Hematological Oncology|February 4, 2020
The landscape of BCR-ABL mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitorsSheng-Hsuan Chien, Hsueng-Mei Liu, Po-Ming Chen, et al.
Pageof 30